Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation.
Thermal ablation procedures including radiofrequency ablation and cryoablation have been increasingly used for treatment for small renal cell carcinoma. Currently, computed tomography and magnetic resonance imaging are usually used to assess residual or recurrent disease after thermal ablation of renal tumor. After thermal ablation, the zone of ablation is usually seen as an area of hypoattenuation on computed tomography and is generally hypointense at T2-weighted magnetic resonance imaging and iso- to hyperintense at T1-weighted imaging relative to renal parenchyma. The ablation zone frequently involutes over time. Residual tumor after thermal ablation is most common at the margin of the ablation zone and often seen as nodular or crescent-shaped areas of contrast enhancement. Accurate assessment of ablated tumors at postprocedural imaging is essential for evaluating the adequacy of treatment and guiding further management. Complications are uncommon and usually minor but should be detected on postprocedural imaging studies.
The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, Baltimore, MD 21287, USA. skawamol@jhmi.edu
Satomi
S
Kawamoto
Stephen B
SB
Solomon
David A
DA
Bluemke
Elliot K
EK
Fishman
D002292:Carcinoma, Renal Cell / Q000601:surgery*; D017115:Catheter Ablation; D003287:Contrast Media; D003452:Cryosurgery; D018450:Disease Progression; D006801:Humans; D021621:Imaging, Three-Dimensional; D007680:Kidney Neoplasms / Q000601:surgery*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011183:Postoperative Complications / Q000175:diagnosis; D011379:Prognosis; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003287:Contrast Media